If you live with hepatitis B, are at least 18 years old, and are a member of HepBCommunity.org, you can complete the short survey about your experiences with hepatitis B. It's on hepbcommunity.org.

When he was 16, John learned during a routine medical checkup that he has hepatitis B. After his mother reacted with tears and concern, he decided that he needed to demonstrate to himself and others that people living with the virus can live full, adventurous lives. John's story is here.

Congratulations to Dr. Ibrahim on a Well-Deserved Promotion

Hepatitis B Foundation President Chari A. Cohen, DrPH, MPH, recently announced the promotion of Yasmin Ibrahim, MD, PhD, MBA, to Public Health Program Director.

Dr. Ibrahim (at left) greeting

Pa. Gov. Josh Shapiro during his recent visit to our campus.

Dr. Ibrahim, who has worked at the Hepatitis B Foundation since 2019, has been directing the patient engagement and clinical trials diversity programs, and has recently led the pursuit of a new FDA grant (for which she is the principal investigator) that is focused on the intersection of COVID-19 and hepatitis B among underserved communities.



Additionally, she responds to the email inquiries that we receive, primarily from people living with hepatitis B.

LaGrippe Research is conducting a study on the experiences of people with hepatitis delta virus (HDV). They would like to speak with people with HDV in the U.S. about their experience with the disease to learn about the effects on their lives.

Each month you would need one hour. LaGrippe Research and offers each participant $125 per month. Your responses will remain anonymous and be kept confidential.

Your feedback will be used by the study's sponsor on how they can help HDV patients now and in the future. 

Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study

Trickey, A; Bivegete, S; Duffell, E; McNaughton, AL; Nerlander, L; Walker, JG; Fraser, H; Hickman, M; Vickerman, P; Brooks-Pollock, E; Christensen, H

[Link to Article]

BMC Infectious Diseases



2023 Jul 10;23(1):457. doi: 10.1186/s12879-023-08433-3.

The authors included almost 600 studies from 31 countries with a total of nearly 42 million people. Along with the general population, the studies looked at subgroups such as pregnant woman, blood donors, prisoners and migrants. They compared Eastern/Southern European countries with Western/Northern European countries. Portugal had the highest estimated prevalence of HBsAg among migrants. They estimated HBV prevalence for each population group within each EU/EAA country and the UK, with general population HBV prevalence to be < 1% in most countries.

Sept. 7-9: Conference on Liver Disease in Africa - Register

Sept. 19-23: International HBV Symposium in Kobe, Japan - Register

Oct. 24-26: African Hepatitis Summit / Register

Nov. 2: The 2023 Bruce Witte Memorial Lecture

April 5, 2024: Hepatitis B Foundation Gala